IPO Details
Bidding Dates
09 Feb 24 - 13 Feb 24
Price Range ₹
1195 - 1258
Total Equity
₹ 899.48Cr
Lot Size
11
Exchange Status
NSE,BSE
IPO Doc
Subscription Rate
Non-Institutional Investor
1.33×
Qualified Institutional Buyers
2.28×
Employees
1.25×
Retail Investors
1.33×
Total subscription Rate
1.53×
IPO Timeline
Offer start
09 Feb 2024
Offer end
13 Feb 2024
Allotment
14 Feb 2024
Refund initiation
15 Feb 2024
Demat transfer
15 Feb 2024
Listing
16 Feb 2024
Offer start
09 Feb 2024
Offer end
13 Feb 2024
Allotment
14 Feb 2024
Refund initiation
15 Feb 2024
Demat transfer
15 Feb 2024
Listing
16 Feb 2024
About Company
Incorporated in 2018, Entero Healthcare Solutions Limited operates as a distributor of healthcare products in India. Leveraging a technology-driven platform, the company provides distribution services for healthcare products to pharmacies, hospitals, and clinics across India. Over the fiscal years 2021, 2022, and 2023, Entero Healthcare Solutions served an increasing number of retail customers, with figures reaching over 39,500, 64,200, and 81,400, respectively. Moreover, they expanded their services to hospital customers, catering to over 1,600, 2,500, and 3,400 hospitals during the same period. The company boasts relationships with more than 1,900 healthcare product manufacturers, granting them access to an extensive inventory comprising over 64,500 product stock-keeping units as of March 31, 2023.
Year Founded
10-01-2018
Promotor Details
Sujesh Vasudevan
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 78.85 | 52.44 |
| Share Capital | 12668193 | 22807166 |
Offer to Public
71,50,100.00 Cr
Project Details
- Funding the long term working capital requirements - 6000cr
- Repayment in full or part, of certain borrowings availed of by our Company and our Subsidiaries - 1236.67cr
Objectives
- Repayment/prepayment, in full or part, of certain borrowings availed of by our Company and our SubsidiariesFunding the long term working capital requirementsPursuing inorganic growth initiatives through acquisitionsGeneral corporate purposes
Highlights
- With 73 warehouses across 37 cities in 19 states and union territories, Entero Healthcare Solutions has a widespread distribution network, allowing them to efficiently reach pharmacies, hospitals, and clinics throughout India.
- The company's broad customer base, which includes over 81,400 pharmacies and 3,400 hospitals, provides a significant market reach and potential for growth.
- Entero Healthcare Solutions' relationships with over 1,900 healthcare product manufacturers give them access to a wide range of products, allowing them to offer diverse options to their customers.
- Utilizing a technology-driven platform enables the company to streamline its operations, enhance efficiency, and provide better services to its customers.
- With a workforce of 3014 people across various departments, Entero Healthcare Solutions contributes to job creation and economic growth.
Challenges
- The healthcare product distribution industry in India is highly competitive, with numerous players vying for market share. Entero Healthcare Solutions faces challenges in maintaining its position amidst intense competition.
- The healthcare industry is subject to stringent regulatory requirements and compliance standards. Adhering to these regulations adds complexity and costs to the company's operations.
- Dependence on a vast network of suppliers and manufacturers introduces supply chain risks, such as disruptions in product availability, logistics issues, and fluctuations in prices.
- Maintaining warehouses, managing inventory, and ensuring timely deliveries entail significant operational costs. Rising operational expenses can impact the company's profitability.
- Economic fluctuations and changes in government policies and regulations can affect consumer spending patterns and business operations. Entero Healthcare Solutions is exposed to risks associated with macroeconomic factors and political developments.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2023 | 13,067.19 | 6,677.26 | -153.54 | -155.37 | -1553.7 |
| 2021 | 8,334.58 | 5,172.12 | -153.54 | -155.37 | -1553.7 |
| 2022 | 11,253.06 | 6,228.40 | -294.39 | -299.20 | -77.7143 |
